Amrize (AMRZ) EBT (2024 - 2026)

Amrize has disclosed EBT across 3 years of filings, most recently posting -$145.0 million for Q1 2026.

• EBT for Q1 2026 came in at -$145.0 million, down 9.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (down 4.26% YoY), and the FY2025 annual result was $1.5 billion, down 8.05% from the prior year.
• EBT came in at -$145.0 million for Q1 2026 at Amrize, down from $392.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $703.0 million in Q3 2024 to a low of -$145.0 million in Q1 2026.
• The 3-year median for EBT is $470.5 million (2025), against an average of $379.5 million.
• Peak annual rise in EBT reached 8.59% in 2025, while the deepest fall reached 11.45% in 2025.
• Amrize's EBT stood at $361.0 million in 2024, then grew by 8.59% to $392.0 million in 2025, then sank by 136.99% to -$145.0 million in 2026.
• The last three EBT figures came in at -$145.0 million (Q1 2026), $392.0 million (Q4 2025), and $689.0 million (Q3 2025), per Business Quant data.